Purpose Survivors of breast cancer (BC) on the non-dominant side have more persistent deficits than those with cancer on the dominant limb. What is not known is whether those with BC use their involved upper limbs more, less, or at the same level as women without BC. Accelerometer use offers a quantifiable method to measure activity levels of upper limbs. The purpose of this study was to quantify the activity levels of the non-dominant involved limb among survivors of BC and compare these values to their dominant limb, as well as the non-dominant limb of a control group. Methods Participants (n = 30) were women with unilateral BC on the non-dominant limb, diagnosed between 6 and 24 months prior to data collection, and a matched healthy grou...
To verify the applicability of a new approach based on the strength curves (SCs) methodology in late...
IntroductionBreast-cancer-related lymphedema affects approximately 25% of breast cancer (BC) survivo...
Background - Breast cancer is the most common cancer in the world and is the primary cancer mortalit...
Purpose Survivors of breast cancer (BC) on the non-dominant side have more persistent deficits than ...
Purpose: Survivors of breast cancer (BC) on the non-dominant side have more persistent deficits than...
Design: This was an observational cross-sectional study. Methods: Women who were diagnosed with brea...
Many women who have experienced breast cancer (BC) report continued impairments in upper extremity (...
Presentation at the World Confederation for Physical Therapy Congress, held May 1-4, 2015, in Singap...
Many women who have experienced breast cancer (BC) report continued impairments in upper extremity (...
Many women who have experienced breast cancer (BC) report continued impairments in upper extremity (...
Background: Self-reported upper extremity function and objective measures are not strongly associate...
Purpose/Hypothesis: Women treated for breast cancer report ongoing upper extremity disability with f...
Breast-cancer-related lymphedema affects ∼25% of breast cancer (BC) survivors and may impact use of ...
Background. Breast-cancer-related lymphedema affects ∼25% of the 2 million breast cancer survivors i...
BACKGROUND: Breast-cancer-related lymphedema affects ~25% of the 2 million breast cancer survivors ...
To verify the applicability of a new approach based on the strength curves (SCs) methodology in late...
IntroductionBreast-cancer-related lymphedema affects approximately 25% of breast cancer (BC) survivo...
Background - Breast cancer is the most common cancer in the world and is the primary cancer mortalit...
Purpose Survivors of breast cancer (BC) on the non-dominant side have more persistent deficits than ...
Purpose: Survivors of breast cancer (BC) on the non-dominant side have more persistent deficits than...
Design: This was an observational cross-sectional study. Methods: Women who were diagnosed with brea...
Many women who have experienced breast cancer (BC) report continued impairments in upper extremity (...
Presentation at the World Confederation for Physical Therapy Congress, held May 1-4, 2015, in Singap...
Many women who have experienced breast cancer (BC) report continued impairments in upper extremity (...
Many women who have experienced breast cancer (BC) report continued impairments in upper extremity (...
Background: Self-reported upper extremity function and objective measures are not strongly associate...
Purpose/Hypothesis: Women treated for breast cancer report ongoing upper extremity disability with f...
Breast-cancer-related lymphedema affects ∼25% of breast cancer (BC) survivors and may impact use of ...
Background. Breast-cancer-related lymphedema affects ∼25% of the 2 million breast cancer survivors i...
BACKGROUND: Breast-cancer-related lymphedema affects ~25% of the 2 million breast cancer survivors ...
To verify the applicability of a new approach based on the strength curves (SCs) methodology in late...
IntroductionBreast-cancer-related lymphedema affects approximately 25% of breast cancer (BC) survivo...
Background - Breast cancer is the most common cancer in the world and is the primary cancer mortalit...